---
title: "BEAT: Net loss and cash outflow declined as clinical and commercial milestones advanced, extending cash runway"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295839342.md"
description: "Clinical validation for heart attack detection advanced ahead of schedule, with initial commercial launch generating positive feedback and first orders in key U.S. markets. Net loss and cash outflow declined year-over-year, extending the cash runway into 2027 and supporting continued execution of strategic priorities.Original document: Heartbeam, Inc. [BEAT] Slides Release — Aug. 13 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-13T20:08:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295839342.md)
  - [en](https://longbridge.com/en/news/295839342.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295839342.md)
generator: "portal-rs"
---

# BEAT: Net loss and cash outflow declined as clinical and commercial milestones advanced, extending cash runway

Clinical validation for heart attack detection advanced ahead of schedule, with initial commercial launch generating positive feedback and first orders in key U.S. markets. Net loss and cash outflow declined year-over-year, extending the cash runway into 2027 and supporting continued execution of strategic priorities.

Original document: Heartbeam, Inc. \[BEAT\] Slides Release — Aug. 13 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [BEAT.US](https://longbridge.com/en/quote/BEAT.US.md)
- [BEATW.US](https://longbridge.com/en/quote/BEATW.US.md)

## Related News & Research

- [HeartBeam posts Q2 presentation outlining heart attack detection progress and initial commercial launch traction](https://longbridge.com/en/news/295840063.md)
- [HeartBeam Buy Rating Reiterated as Clinical and Commercial Momentum Strengthens; $2 Price Target Maintained](https://longbridge.com/en/news/296257396.md)
- [AI Was Supposed to Kill Wix. Google Just Gave It a Way to Fight Back.](https://longbridge.com/en/news/297433684.md)
- [RLO: Tripling revenue ambition, global defence focus, and innovation drive long-term growth](https://longbridge.com/en/news/297759336.md)
- [CRET: Q2 2026 saw higher sales and improved margins, but growth is limited by financing constraints](https://longbridge.com/en/news/297468890.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**